Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Jarman
Endocrine, Pharmacokinetic and Clinical Studies of the Aromatase Inhibitor 3-Ethyl-3-(4-Pyridyl)piperidine-2,6-Dione ('Pyridoglutethimide') in Postmenopausal Breast Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Related publications
Ethyl 4-{2,6-Dichloro-4-[3-(2,6-Difluorobenzoyl)ureido]phenoxy}butanoate
Acta Crystallographica Section E Structure Reports Online
3-Ethyl-Cis-2,6-Diphenylpiperidine
Acta Crystallographica Section E Structure Reports Online
5-Chloro-5′′-(4-Chlorobenzylidene)-4′-(4-Chlorophenyl)-1′,1′′-Dimethyldispiro[indoline-3,2′-Pyrrolidine-3′,3′′-Piperidine]-2,4′′-Dione
Acta Crystallographica Section E Structure Reports Online
Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women
Nowotwory
Cancer Research
Oncology
Synthesis and Asymmetric Hydrogenation of (3e)-1-Benzyl-3-[(2-Oxopyridin-1(2h)-Yl)methylidene]piperidine-2,6-Dione
Chemical Communications
Surfaces
Alloys
Materials Chemistry
Coatings
Metals
Optical
Magnetic Materials
Films
Catalysis
Chemistry
Electronic
Composites
Ceramics
Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index
British Journal of Cancer
Cancer Research
Oncology
Ethyl 4-Anilino-2,6-Bis(4-Chlorophenyl)-1-Phenyl-1,2,5,6-Tetrahydropyridine-3-Carboxylate
Acta Crystallographica Section E Structure Reports Online
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
